Moreover, upon deeper analysis, it was observed that the combination treatment of SAM+anti-PD-1 acted on a group of specific genes that are aberrantly expressed in melanoma tumors, which might underlie the therapeutic effects. Here, PDCD1 is linked to melanoma.